CCEL
CryoCell International Inc
4.00$
-4.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -12.3% | +0.8% | +1.4% | +0.6% | +2.8% | -0.5% | +0.1% | -2.0% | -2.3% | -1.4% | -0.3% | |
| – | -4.9% | 0.0% | +7.5% | +5.0% | +17.8% | -0.4% | +4.3% | -10.6% | +0.7% | -5.8% | +2.1% | |
| – | -30.5% | -39.1% | +89.9% | -57.9% | +184.1% | -60.2% | -38.4% | +92.9% | +20.3% | -21.7% | +103.2% | |
| – | -18.8% | -0.1% | +56.1% | +39.0% | +64.4% | -0.5% | +27.3% | -27.3% | +2.3% | -12.0% | +9.0% | |
| – | +2.2% | +2.3% | +1.6% | +0.6% | +6.3% | -1.3% | -3.9% | -1.4% | +0.2% | -0.4% | +1.4% | |
| – | -27.7% | -1.8% | -6.2% | +3.3% | -10.1% | +11.1% | -7.4% | -3.2% | -37.6% | -12.7% | -13.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -93.1% | -1.7% | -1.7% | -1.8% | -1.8% | -1.8% | -1.9% | -1.5% | -1.3% | -1.3% | -1.3% | |
| – | +3.5% | -0.3% | +1.7% | -1.1% | +7.4% | +1.5% | +1.2% | -2.5% | +3.0% | -1.3% | -1.0% | |
| – | +12.4% | -7.2% | +0.4% | -10.4% | +24.0% | +0.6% | +0.1% | -15.2% | +7.3% | -10.3% | -10.3% | |
| – | -48.0% | +48.4% | +95.8% | -40.7% | +48.1% | +26.3% | +39.6% | -50.0% | -19.8% | -30.5% | -69.5% | |
| – | +14.0% | -5.6% | -39.0% | +9.5% | -5.9% | +45.8% | -18.3% | +16.5% | +9.9% | +15.0% | -13.8% | |
| – | -0.5% | -0.5% | -0.4% | -0.3% | -0.2% | -0.4% | -0.4% | – | – | -0.5% | -0.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | -1.0% | -0.3% | -0.7% | +0.5% | -0.2% | -0.9% | -0.6% | -0.1% | -0.2% | 0.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.